Results 201 to 210 of about 29,252 (243)

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Lancet, The, 2022
Parvinder Aley, Sue Charlton, Christopher J A Duncan   +2 more
exaly  

Heterologous Transplantation of Human Tumors

Science, 1947
openaire   +2 more sources

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

Science, 2022
Catherine J Reynolds, Joseph M Gibbons, Corinna Pade   +2 more
exaly  

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Lancet, The, 2020
Denis Y Logunov, Inna V Dolzhikova, Olga Zubkova   +2 more
exaly  

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine, 2022
Robert L Atmar, Kirsten E Lyke, Meagan Bolles   +2 more
exaly  

Heterologous transplantation of human neoplasms including lymphomas

Cancer, 1951
S B, ANDRUS, G F, MEISSNER, C M, WHORTON
openaire   +2 more sources

Heterologous Corneal Transplants in Rabbits

American Journal of Ophthalmology, 1959
John H.J. Sykes, Louis J. Girard
openaire   +1 more source

Heterologous transplantation of cancer

Zeitschrift f�r Krebsforschung, 1957
openaire   +1 more source

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

Nature Medicine, 2021
Tina Schmidt, David Schub, Janine Mihm
exaly  

[Heterologous transplantation of tumors].

Oncologia, 2003
W, BOLLAG, C, MEYER
openaire   +1 more source